This paper is in the following e-collection/theme issue:

RCTs - Protocols/Proposals (funded, already peer-reviewed, non-eHealth) (172)

Published on in Vol 3, No 2 (2014): Apr-Jun

Dabigatran Versus Warfarin After Bioprosthesis Valve Replacement for the Management of Atrial Fibrillation Postoperatively: Protocol

Dabigatran Versus Warfarin After Bioprosthesis Valve Replacement for the Management of Atrial Fibrillation Postoperatively: Protocol

Dabigatran Versus Warfarin After Bioprosthesis Valve Replacement for the Management of Atrial Fibrillation Postoperatively: Protocol

Authors of this article:

Andre Rodrigues Duraes1 Author Orcid Image ;   Pollianna DS Roriz2 ;   Fabio V Bulhoes2 ;   Bianca DA Nunes2 ;   Juliana QV Muniz2 ;   Italvar NDCR Neto2 ;   Andre MS Fernandes2 ;   Francisco JFBD Reis2 ;   Edmundo JN Camara2 ;   Erenaldo DSR Junior2 ;   Deusdeth TS Segundo2 ;   Felipe Pinho E Albuquerque Silva2 ;   Roque Aras2
Article Authors Cited by (3) Tweetations Metrics

Journals

  1. Fauchier L, Philippart R, Clementy N, Bourguignon T, Angoulvant D, Ivanes F, Babuty D, Bernard A. How to define valvular atrial fibrillation?. Archives of Cardiovascular Diseases 2015;108(10):530 View
  2. Durães A, de Souza Roriz P, de Almeida Nunes B, Albuquerque F, de Bulhões F, de Souza Fernandes A, Aras R. Dabigatran Versus Warfarin After Bioprosthesis Valve Replacement for the Management of Atrial Fibrillation Postoperatively: DAWA Pilot Study. Drugs in R&D 2016;16(2):149 View
  3. Wang Y, Lin M, Ge S, Feng J, Ang R, Asher E, Cinier G, Tardo D, Thomson R. Mechanical valve replacement without anticoagulation: a case report. European Heart Journal - Case Reports 2021;5(1) View